TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 13, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 2
- 0 vs. Q3 2025
- Portfolio value
- $255.1M
- −$18.8M (−6.9%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | COM | 4,473,958 | $185.4M | 72.7% | −1,600,000−26.3% | Reduced | History |
| TNGXTango Therapeutics, Inc. | COM | 7,874,574 | $69.8M | 27.3% | −5,989,401−43.2% | Reduced | History |